Business · 20/11/2012Updated: 10/17/2026 · 1 min read

FDA Releases Draft Guidance for IRB Responsibilities in Clinical Investigations

The FDA has made available a draft guidance document to help IRBs, clinical investigators, and sponsors ensure the protection of human subjects in clinical trials by reviewing investigator qualifications, research site adequacy, and IND/IDE requirements.